Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
About Index
Index
By TNW
Log in
Register
Tvardi Therapeutics
3205
Tvardi Therapeutics
Technology
Biotechnology
Health Care
Medical
Therapeutics
Tvardi is a clinical stage, private biotechnology company developing a new class of breakthrough medicines for diverse cancers.
Suggest edits
Founded
2017
Raised
$14M
Follow us
Also headquartered in Houston
NASA
DialWebHosting
Cameron
Kinder Morgan
ConocoPhillips
real
EVgo
Halliburton
Schlumberger
Sean Spicer
Companies in the same industry
Tango Therapeutics
GamaMabs Pharma
Caldan Therapeutics
Chordia Therapeutics
Crescendo Biologics
Exocobio
Lunac Therapeutics
Encoded Genomics Inc
ABM Therapeutics
LUCA Science
Alexa global traffic share
Overview
Funding
2
Add info
Latest funding
$5,000,000
Grant - 2020
National Institutes of Health (NIH)
V Foundation
Cancer Prevention & Research Institute of Texas (CPRIT)
$9,000,000
Venture capital (Series A) - 2018
Team Size
1–10
Employees
I work here
Location
Houston
,
United States
Headquarters
Explore Houston
$5,000,000
Grant
FinSMEs
Tvardi Therapeutics Receives $5M in Grant Funding
$9,000,000
Venture capital (Series A)
PE HUB
Tvardi Therapeutics lands $9 mln Series A
